2024Jhep Reports : Innovation in Hepatology6 (3) : 100989
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Gömer A, Dinkelborg K, Klöhn M, Jagst M, Wißing M, Frericks N, Nörenberg P, Behrendt P, Cornberg M, Wedemeyer H, Steinmann E, Maasoumy B, Todt D
2024Nature Communications15 (1) : 114
BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination
van Meijgaarden K, Li W, Moorlag S, Koeken V, Koenen H, Joosten L, Vyakarnam A, Ahmed A, Rakshit S, Adiga V, Ottenhoff T, Li Y, Netea M, Joosten S
2024Gut Microbes16 (1) : 2397058
Gut microbiota-derived butyrate selectively interferes with growth of carbapenem-resistant Escherichia coli based on their resistance mechanism
Happ E, Schulze K, Afrin Z, Woltemate S, Görner P, Ziesing S, Schlüter D, Geffers R, Winstel V, Vital M
2024Ebiomedicine99 : 104935
11-deoxycortisol positively correlates with T cell immune traits in physiological conditions
Peng C, Jiang X, Jaeger M, van Houten P, van Herwaarden A, Koeken V, Moorlag S, Mourits V, Lemmers H, Dijkstra H, Koenen H, Joosten I, van Cranenbroek B, Li Y, Joosten L, Netea M, Netea-Maier R, Xu C
2024The Journal of Infection88 (1) : 57-60
Memory B cells anticipate SARS-CoV-2 variants through somatic hypermutation
Bruhn M, Obara M, Chiyyeadu A, Costa B, Salam A, Ziegler A, Waltl I, Pavlou A, Bonifacius A, Hoffmann M, Graalmann T, Pöhlmann S, Eiz-Vesper B, Schambach A, Kalinke U
2024The Lancet. Infectious Diseases24 (1) : e1-e3
Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination
Stankov M, Hoffmann M, Gutierrez Jauregui R, Cossmann A, Morillas Ramos G, Graalmann T, Winter E, Friedrichsen M, Ravens I, Ilievska T, Ristenpart J, Schimrock A, Willenzon S, Ahrenstorf G, Witte T, Förster R, Kempf A, Pöhlmann S, Hammerschmidt S, Dopfer-Jablonka A, Behrens G
2023Plos Pathogens19 (12) : e1011892
Pathogen-driven nucleotide overload triggers mitochondria-centered cell death in phagocytes
Schwermann N, Haller R, Koch S, Grassl G, Winstel V
2023Rmd Open9 (4) : e003507
Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in PEPD
Atschekzei F, Fedchenko M, Elsayed A, Dubrowinskaja N, Graalmann T, Ringshausen F, Witte T, Sogkas G
2023Hepatology (baltimore, Md.)78 (6) : 1882-1895
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients
Gömer A, Klöhn M, Jagst M, Nocke M, Pischke S, Horvatits T, Schulze Zur Wiesch J, Müller T, Hardtke S, Cornberg M, Wedemeyer H, Behrendt P, Steinmann E, Todt D
2023Emerging Microbes & Infections12 (2) : 2251598
Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing
Stahl Y, Kabar I, Heinzow H, Maasoumy B, Bremer B, Wedemeyer H, Schmidt H, Pietschmann T, Schlevogt B, Behrendt P